References

Greener M Why the NHS needs to radically rethink chronic wound care. Independent Nurse. 2019; 2019:(10)12-15 https://doi.org/10.12968/indn.2019.10.12

Friman A, Edström DW, Edelbring S General practitioners' perceptions of their role and their collaboration with district nurses in wound care. Prim Health Care Res Dev. 2018; 20:1-8 https://doi.org/10.1017/S48

Nunan R, Harding KG, Martin P Clinical challenges of chronic wounds: searching for an optimal animal model to recapitulate their complexity. Dis Model Mech. 2014; 7:(11)1205-1213 https://doi.org/10.1242/dmm.016782

Rogers LC How COVID-19 is changing wound care and why you should be preparing now for the next wave. Today's Wound Clinic. 2020; 14:(6)10-12

Rogers LC, Lavery LA, Joseph WS, Armstrong DG All feet on deck—the role of podiatry during the covid-19 pandemic: preventing hospitalizations in an overburdened healthcare system, reducing amputation and death in people with diabetes. J Am Podiatr Med Assoc. 2020; 0000 https://doi.org/10.7547/20-051

Frykberg RG, Banks J Challenges in the treatment of chronic wounds. Adv Wound Care. 2015; 4:(9)560-582 https://doi.org/10.1089/wound.2015.0635

Zhao R, Liang H, Clarke E Inflammation in chronic wounds. Int J Mol Sci. 2016; 17:(12) https://doi.org/10.3390/ijms17122085

Samaniego-Ruiz MJ, Llatas FP, Jiménez OS Assessment of chronic wounds in adults: an integrative review. Rev Esc Enferm USP. 2018; 52

Stacey M Why wounds don't heal?. Wounds Int. 2016; 7:(1)16-21

Bowers S, Franco E Chronic wounds: evaluation and management. Am Fam Physician. 2020; 101:(3)159-166

Harding KG, Queen D A 25-year wound care journey within the evolution of wound care. Adv Skin Wound Care. 2012; 25:(2)66-70 https://doi.org/10.1097/01.ASW.0000411406.13178.c5

Vermeulen H, Ubbink DT, Goossens A Systematic review of dressings and topical agents for surgical wounds healing by secondary intention. Br J Surg. 2005; 92:(6)665-672 https://doi.org/10.1002/bjs.5055

Fan K, Tang J, Escandon J, Kirsner RS State of the art in topical wound-healing products. Plast Reconstr Surg. 2011; 127:44S-59S https://doi.org/10.1097/PRS.0b013e3181fbe275

Kyaw B, Järbrink K, Martinengo L Need for improved definition of ”chronic wounds” in clinical studies. Acta Derm Venereol. 2018; 98:(1)157-158 https://doi.org/10.2340/00015555-2786

Lazaro JL, Izzo V, Meaume S Elevated levels of matrix metalloproteinases and chronic wound healing: an updated review of clinical evidence. J Wound Care. 2016; 25:(5)277-287 https://doi.org/10.12968/jowc.2016.25.5.277

Gibson D, Cullen B, Legerstee R MMPs made easy. Wounds Int. 2009; 1:(1)1-6

Schultz GS, Sibbald RG, Falanga V Wound bed preparation: a systematic approach to wound management. Wound Repair Regen. 2003; 11:(s1 Suppl 1)S1-S28 https://doi.org/10.1046/j.1524-475X.11.s2.1.x

Raffetto JD Which dressings reduce inflammation and improve venous leg ulcer healing. Phlebology. 2014; 29:(1 suppl)157-164 https://doi.org/10.1177/0268355514529225

Supporting evidence based practice: a clinical review of TLC healing matrix. 2015. http://bit.ly/2sHLVyU (accessed 18 March 2021)

Lázaro-Martínez JL, García-Madrid M, García-Alamino JM Increasing transcutaneous oxygen pressure in patients with neuroischemic diabetic foot ulcers treated with a sucrose octasulfate dressing: a pilot study. Int J Low Extrem Wounds. 2020; https://doi.org/10.1177/1534734620952244

Michigan State Universtiy. PubMed, Web of Science, or Google Scholar? A behind-the-scenes guide for life scientists: which one is best: PubMed, Web of Science, or Google Scholar?. https://tinyurl.com/yyjfh73b (accessed 18 March 2021)

Aslam S, Emmanuel P Formulating a researchable question: a critical step for facilitating good clinical research. Indian J Sex Transm Dis AIDS. 2010; 31:(1)47-50 https://doi.org/10.4103/2589-0557.69003

Burns PB, Rohrich RJ, Chung KC The levels of evidence and their role in evidence-based medicine. Plast Reconstr Surg. 2011; 128:(1)305-310 https://doi.org/10.1097/PRS.0b013e318219c171

Ho PM, Peterson PN, Masoudi FA Evaluating the evidence. Circulation. 2008; 118:(16)1675-1684 https://doi.org/10.1161/CIRCULATIONAHA.107.721357

Tonelli M Evidence-based medicine and clinical expertise. Virtual Mentor. 2006; 8:(2)71-74

Charbonneau DH The Cochrane Library. J Med Libr Assoc. 2005; 93:(3)409-410

Jung JH, Franco JV, Dahm P Moving towards evidence-based clinical practice guidelines. Urogenit Tract Infect. 2018; 13:(3)45-50 https://doi.org/10.14777/uti.2018.13.3.45

Edmonds M, Lázaro-Martínez JL, Alfayate-García JM Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): an international, multicentre, double-blind, randomised, controlled trial. Lancet Diabetes Endocrinol. 2018; 6:(3)186-196 https://doi.org/10.1016/S2213-8587(17)30438-2

Meaume S, Truchetet F, Cambazard F A randomized, controlled, double-blind prospective trial with a Lipido-Colloid Technology-Nano-OligoSaccharide Factor wound dressing in the local management of venous leg ulcers. Wound Repair Regen. 2012; 20:(4)500-511 https://doi.org/10.1111/j.1524-475X.2012.00797.x

Schmutz JL, Meaume S, Fays S Evaluation of the nano-oligosaccharide factor lipido-colloid matrix in the local management of venous leg ulcers: results of a randomised, controlled trial. Int Wound J. 2008; 5:(2)172-182 https://doi.org/10.1111/j.1742-481X.2008.00453.x

Richard JL, Martini J, Faraill MB Management of diabetic foot ulcers with a TLC-NOSF wound dressing. J Wound Care. 2012; 21:(3)142-147 https://doi.org/10.12968/jowc.2012.21.3.142

Lobmann R, Augustin M, Lawall H Cost-effectiveness of TLC-sucrose octasulfate versus control dressings in the treatment of diabetic foot ulcers. J Wound Care. 2019; 28:(12)808-816 https://doi.org/10.12968/jowc.2019.28.12.808

Lázaro-Martínez JL, Edmonds M, Rayman G Optimal wound closure of diabetic foot ulcers with early initiation of TLC-NOSF treatment: post-hoc analysis of Explorer. J Wound Care. 2019; 28:(6)358-367 https://doi.org/10.12968/jowc.2019.28.6.358

Meaume S, Dompmartin A, Lok C Quality of life in patients with leg ulcers: results from CHALLENGE, a double-blind randomised controlled trial. J Wound Care. 2017; 26:(7)368-379 https://doi.org/10.12968/jowc.2017.26.7.368

Augustin M, Herberger K, Kroeger K Cost-effectiveness of treating vascular leg ulcers with UrgoStart and UrgoCell Contact. Int Wound J. 2016; 13:(1)82-87 https://doi.org/10.1111/iwj.12238

Münter KC, Meaume S, Augustin M The reality of routine practice: a pooled data analysis on chronic wounds treated with TLC-NOSF wound dressings. J Wound Care. 2017; 26:(Sup2)S4-S15 https://doi.org/10.12968/jowc.2017.26.sup2.s4

Dissemond J, Lützkendorf S, Dietlein M Clinical evaluation of polyabsorbent TLC-NOSF dressings on chronic wounds: a prospective, observational, multicentre study of 1140 patients. J Wound Care. 2020; 29:(6)350-361 https://doi.org/10.12968/jowc.2020.29.6.350

Sigal ML, Addala A, Maillard H Evaluation of TLC-NOSF dressing with poly-absorbent fibres in exuding leg ulcers: two multicentric, single-arm, prospective, open-label clinical trials. J Wound Care. 2019; 28:(3)164-175 https://doi.org/10.12968/jowc.2019.28.3.164

Allaert FA [Observational study on the efficacy of TLC-Ag and TLC-NOSF on chronic wounds. [In French.] Soins. 2014; 785:15-18

Schaper NC, Netten JJ, Apelqvist J Practical guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes Metab Res Rev. 2020; 36:(Suppl 1) https://doi.org/10.1002/dmrr.3266

Arroyo Ana A, Alvarez Vazquez JC, Blasco Garcia C Cost-effectiveness of a TLC-NOSF polyurethane foam dressing. Rev Enferm. 2012; 35:(11)27-32

Betts A, Yeowell G, Odeyemi I, Fatoye F PMD41-the budget impact and cost-consequence of treating diabetic foot ulcers with URGOSTART. Value Health. 2018; 21 https://doi.org/10.1016/j.jval.2018.09.1490

Betts A, Odeyemi I, Yeowell G PMD103-cost-effectiveness and cost-utility analysis of treating leg ulcers with URGOSTART compared to a neutral dressing. Value Health. 2018; 21 https://doi.org/10.1016/j.jval.2018.09.1552

National Institute for Health and Care Excellence. UrgoStart for treating diabetic foot ulcers and leg ulcers. 2019. https://tinyurl.com/358f3e8d (accessed 23 March 2021)

Conde-Montero E, Bohbot S, Grado Sanz R Association of autologous punch grafting, TLC-NOSF dressing and multitype compression therapy to rapidly achieve wound closure in hard-to-heal venous leg ulcers. J Médecine Vasculaire. 2020; 45:(6)316-325 https://doi.org/10.1016/j.jdmv.2020.10.123

Galea E, Khatib M Addressing wound chronicity factors: UrgoClean Ag and UrgoStart case studies. Wounds Middle East. 2020; 7:(1)25-29

Blasco Garcia C, Segovia Gomez T, Bermejo Martinez M [Clinical cases about the therapeutic use of debriding dressing hidrodetersive polyacrylate fibers with tlc and foam dressings TLC-NOSF polyurethane in chronic wounds.]. [In Spanish.] Rev Enferm. 2012; 35:(10)9-14

Piťhová P [The usage of sequential wound management with UrgoClean Ag and UrgoStart dressing in the diabetic foot treatment]. [In Czech.] Kazuistiky v diabetologii. 2018; 16:(3)10-12

Stryja J [The use of therapeutic dressing UrgoStart in a treatment of ulceration in diabetic foot syndrome]. [In Czech.] Kazuistiky v diabetologii. 2018; 16:(1)33-36

Venerová J [Use of modern covering materials with lipid-colloidal layer (TLC) in the local treatment of chronic neuroischemic defect in patients with type 2 diabetes mellitus]. [in Czech]. Kazuistiky v diabetologii. 2018; 16:(2)33-35

Galea E Taking up the challenge: neuroischaemic diabetic foot ulcers. Wound Practice Research. 2018; 26

Double-blind study. 2019. https://tinyurl.com/yzlfzagz (accessed 18 March 2021)

Brölmann FE, Eskes AM, Sumpio BE Fundamentals of randomized clinical trials in wound care: reporting standards. Wound Repair Regen. 2013; 21:(5)641-647 https://doi.org/10.1111/wrr.12087

Crowe S, Cresswell K, Robertson A The case study approach. BMC Med Res Methodol. 2011; 11:(1) https://doi.org/10.1186/1471-2288-11-100

Dissemond J, Augustin M, Dietlein M Efficacy of MMP-inhibiting wound dressings in the treatment of chronic wounds: a systematic review. J Wound Care. 2020; 29:(2)102-118 https://doi.org/10.12968/jowc.2020.29.2.102

Dixon D, Edmonds M Managing diabetic foot ulcers: pharmacotherapy for wound healing. Drugs. 2021; 81:(1)29-56 https://doi.org/10.1007/s40265-020-01415-8

Benefits of sucrose octasulfate (TLC-NOSF) dressings in the treatment of chronic wounds: a systematic review

01 April 2021

Abstract

Objective:

Management of chronic wounds remains one of the major challenges for health professionals and patients. An evidence-based decision is important to ensure that patients are receiving the best treatment proven to reduce healing time and improve outcomes, including economic benefits and patients' health-related quality of life (HRQoL). Due to recent restrictions because of the COVID-19 pandemic, including closure of wound care centres within hospitals and a drop in patient volume, chronic wound management needs simple-to-use dressings which are still effective and evidence-based solutions. This systematic review was conducted to identify the clinical evidence available on a sucrose octasulfate dressing (TLC-NOSF, UrgoStart dressing range, Laboratoires Urgo, France) to explore its efficacy in the management of chronic wounds, particularly lower limb ulcers, diabetic foot ulcers and pressure ulcers.

Method:

A literature search of PubMed, Cochrane Library and Google Scholar was conducted based on the PICO model (patient/population, intervention, comparison and outcomes) to retrieve publications of different levels of evidence in order to evaluate outcomes of the use of TLC-NOSF dressings.

Results:

A total of 21 publications of different levels, ranging from double-blind randomised control trials to case reports, involving over 12,000 patients, were identified through PubMed, with a further eight publications through Google Scholar and two publications through Cochrane Library. A total of seven results were omitted due to the lack of relevance or repetition.

Conclusion:

All the evidence provided suggest that these dressings provide clinicians with an evidence-based option for the management of chronic wounds; that the TLC-NOSF dressings are beneficial in promoting the healing process, reducing healing times, enhancing patients' HRQoL, and in allowing a more cost-effective procedure.

Chronic wounds present a real challenge to clinicians involved in wound management, not only for those health professionals who work in wound care centres, but for general practitioners and community nurses who regularly manage these types of wounds.1,2 Chronic wounds also place a financial burden on healthcare systems and, perhaps more importantly, they have devastating effects on patients and their families.3 This challenge has been increased during the COVID-19 pandemic due to a workforce shortage, repurposing of health professionals from ‘non-essential’ services such as wound care, as well as an estimated 40% drop in patient volume as patients choose not to expose themselves to the risk of infection.4 However, it is essential that patients with chronic wounds still receive appropriate care while minimising their need to visit hospital or other healthcare settings.5

Register now to continue reading

Thank you for visiting Journal of Wound Care's Silk Road Supplement and reading some of our peer-reviewed resources for healthcare professionals across Asia. To read more, please register today.